Glenmark Life Sciences (GLS.NSE) Q4 2024 Earnings

Oct 24Confirmed
Q1 2024
Q3 2024
Q4 2024
7.63
9.3
10.97
12.64

Details

Expected EPS
10.0363802
Actual EPS
7.6276489519999995
Surprise EPS
-2.41
Surprise Percent
-24%

Description

⁨Glenmark Life Sciences⁩ (⁦GLS.NSE⁩) has reported earnings of ⁦7.6276489519999995⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts